Trajectory of Vector-adaptive Chikungunya Virus Evolution
Trajectory of Vector-adaptive Chikungunya Virus Evolution
批准号:
9185262
负责人:
Scott C Weaver
金额:
$45.41万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-12-01 至 2020-11-30
关键词:
AcidsAddressAedesAffectAfricaAfricanAmericasArbovirusesArthralgiaAsiaAsian IndianAsiansBlood CirculationCaribbean regionCellsCentral AmericaChikungunya virusChronicCulicidaeDengue VirusDependenceDisease OutbreaksEconomicsEpidemicEuropeEvolutionFutureGeneticGlycoproteinsGoalsHealthHumanHuman papillomavirus 16 E1 proteinIndian OceanInfectionInterventionLatin AmericaMediatingModernizationMolecular ConformationMutationNatureNorth AmericaOceaniaPatternPersonsPhenotypePhylogenetic AnalysisPopulationProteinsPublic HealthRNA VirusesRecording of previous eventsReunion IslandRiskRoleSeriesSouth AfricanSouth AmericaSoutheastern AsiaTestingTherapeuticTimeVaccinesVertebral columnViralVirusVirus Diseaseschikungunyadeep sequencingenzooticfitnessgenetic approachimprovednonhuman primateprospectivepublic health relevanceresponsetransmission processvectorvector controlvector mosquitoviral transmission
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Chikungunya (CHIKV) is a reemerging mosquito-borne virus that originates in an enzootic African cycle but periodically initiates an urban cycle involving human amplification hosts and the urban vector mosquitoes, Aedes aegypti and recently, A. albopictus. Since 2004, Spread via infected travelers has introduced CHIKV into Asia, Europe, Oceania and the Americas with millions of cases of severe, debilitating, often chronic arthralgia. A hallmark of recently emerged strains in the Indian Ocean Lineage (IOL) has been the evolution of a series of A. albopictus-adaptive substitutions in the envelope glycoproteins. These mutations increase transmission efficiency by this species in the Indian Ocean basin and Asia. A pattern of IOL substitutions focused near the fusion loop of the E1 protein (residue 226) and in the acid sensitive region of E2 suggests an effect on CHIKV entry into mosquito cells by altering the pH threshold for conformational changes in the viral spikes. This pattern allowed us to predict additional adaptive E2 substitutions, never detected in nature, and to show that a combination of these substitutions will soon result in even more efficient transmission by A. albopictus. However, the dependence of these "second-step" E2 mutations on E1-226, and their phenotypes in the genetic background of the Asian lineage recently introduced into the Americas, remain unknown. Furthermore, the history of vector-specific adaptation of the Asian Lineage has never been explored. Therefore, the vector-adaptive trajectory of the Asian CHIKV lineage now in the Americas and its effect on spread and endemicity remains unpredictable despite major public health implications. Critical gaps in understanding include: 1) Has/will the Asian lineage (further) adapt for A. aegypti transmission in the Americas, and will such adaptation affect transmission by A. albopictus?; 2) Can A. albopictus-adaptive E2 substitutions increase Asian strain infectivity for A. albopictus or A. aegypti? and; 3) Can we predict additional vector-adaptive CHIKV evolution as spread continues in the Americas? We address these critical questions using 4 specific aims: 1. Characterize the vector-adaptive evolutionary history of the Asian CHIKV lineage since 1958, and use the findings to predict the future evolutionary trajectory of this strain in the Americas. . Follow the evolution of both Asian and IOL CHIKV strains in Asia and the Americas to identify additional vector-adaptive evolution. 3. Determine the effects of "second-step" vector-adaptive E2 substitutions on infectivity for A. albopictus or A. aegypti in the Asian backbone. 4. Use a prospective approach with deep sequencing of experimentally manipulated CHIKV strains from the Americas to identify potential adaptive mutations that could affect vector usage in the Western Hemisphere. The results will not only improve prediction of imminent and future CHIKV epidemics, but also will inform surveillance and vector control efforts to directly impact public health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
West African Center for Emerging Infectious Diseases
-
批准号:10427336
-
项目类别:
-
资助金额:$154.36万
-
财政年份:2020
-
负责人:Scott C Weaver
-
依托单位:
West African Center for Emerging Infectious Diseases
-
批准号:10187519
-
项目类别:
-
资助金额:$154.53万
-
财政年份:2020
-
负责人:Scott C Weaver
-
依托单位:
West African Center for Emerging Infectious Diseases
-
批准号:10626824
-
项目类别:
-
资助金额:$154.22万
-
财政年份:2020
-
负责人:Scott C Weaver
-
依托单位:
West African Center for Emerging Infectious Diseases
-
批准号:10468361
-
项目类别:
-
资助金额:$52.1万
-
财政年份:2020
-
负责人:Scott C Weaver
-
依托单位:
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)
-
批准号:10598513
-
项目类别:
-
资助金额:$98.75万
-
财政年份:2016
-
负责人:Scott C Weaver
-
依托单位:
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)
-
批准号:9210602
-
项目类别:
-
资助金额:$92.49万
-
财政年份:2016
-
负责人:Scott C Weaver
-
依托单位:
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)
-
批准号:8999458
-
项目类别:
-
资助金额:$76.95万
-
财政年份:2016
-
负责人:Scott C Weaver
-
依托单位:
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)
-
批准号:10170884
-
项目类别:
-
资助金额:$98.75万
-
财政年份:2016
-
负责人:Scott C Weaver
-
依托单位:
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)
-
批准号:10391524
-
项目类别:
-
资助金额:$98.75万
-
财政年份:2016
-
负责人:Scott C Weaver
-
依托单位:
Eastern Equine Encephalitis Emergence in Panama
-
批准号:8927903
-
项目类别:
-
资助金额:$24.53万
-
财政年份:2015
-
负责人:Scott C Weaver
-
依托单位:
Trajectory of Vector-adaptive Chikungunya Virus Evolution
-
批准号:9009006
-
项目类别:
-
资助金额:$46.92万
-
财政年份:2015
-
负责人:Scott C Weaver
-
依托单位:
Eastern Equine Encephalitis Emergence in Panama
-
批准号:9091415
-
项目类别:
-
资助金额:$19.28万
-
财政年份:2015
-
负责人:Scott C Weaver
-
依托单位:
Alphavirus Vaccines for Biodefense
-
批准号:8377052
-
项目类别:
-
资助金额:$90.69万
-
财政年份:2012
-
负责人:Scott C Weaver
-
依托单位:
Novel Vaccine Technology for Chikungunya
-
批准号:8520171
-
项目类别:
-
资助金额:$95.44万
-
财政年份:2011
-
负责人:Scott C Weaver
-
依托单位:
Novel Vaccine Technology for Chikungunya
-
批准号:8308393
-
项目类别:
-
资助金额:$56.35万
-
财政年份:2011
-
负责人:Scott C Weaver
-
依托单位:
Novel Vaccine Technology for Chikungunya
-
批准号:8704359
-
项目类别:
-
资助金额:$64.2万
-
财政年份:2011
-
负责人:Scott C Weaver
-
依托单位:
Novel Vaccine Technology for Chikungunya
-
批准号:8077195
-
项目类别:
-
资助金额:$100.72万
-
财政年份:2011
-
负责人:Scott C Weaver
-
依托单位:
VENEZUELAN EQUINE ENCEPHALOMYELITIS VIRUS
-
批准号:8361058
-
项目类别:
-
资助金额:$2.45万
-
财政年份:2011
-
负责人:Scott C Weaver
-
依托单位:
Alphavirus Vaccines for Biodefense
-
批准号:8233016
-
项目类别:
-
资助金额:$98.79万
-
财政年份:2011
-
负责人:Scott C Weaver
-
依托单位:
BARMAH FOREST VIRUS (BFV)
-
批准号:8361135
-
项目类别:
-
资助金额:$1.23万
-
财政年份:2011
-
负责人:Scott C Weaver
-
依托单位:
海外基金